Detalhe da pesquisa
1.
Access to Novel Drugs for Non-Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group Analysis.
Oncologist
; 25(3): e598-e601, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162818
2.
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.
Lancet Oncol
; 16(7): 763-74, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26045340
3.
Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study.
Lancet Oncol
; 16(3): 328-37, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25701171
4.
Is there a correlation between peripheral blood expression of angiogenic transcriptional factors/receptors and colorectal cancer?
J BUON
; 20(5): 1193-200, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26537064
5.
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial.
Lancet Oncol
; 15(7): 700-12, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24831977
6.
Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study.
Lancet Oncol
; 13(3): 292-9, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22336221
7.
Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results.
J Clin Oncol
; 41(30): 4756-4767, 2023 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37651676
8.
Real-World Testing Practices, Treatment Patterns and Clinical Outcomes in Patients from Central Eastern Europe with EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Retrospective Chart Review Study (REFLECT).
Curr Oncol
; 29(8): 5833-5845, 2022 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36005198
9.
Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors.
Eur Urol
; 78(6): 822-830, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32811715
10.
Malignant primary pulmonary tumor with hemangiopericytoma-like features: conventional hemangiopericytoma versus solitary fibrous tumor.
Clin Lung Cancer
; 8(8): 504-8, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17922977
11.
Altered left ventricular diastolic performance in oncologic patients treated with epirubicin.
Congest Heart Fail
; 13(4): 215-20, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17673874
12.
FOLFOX4 Plus Cetuximab for Patients With Previously Untreated Metastatic Colorectal Cancer According to Tumor RAS and BRAF Mutation Status: Updated Analysis of the CECOG/CORE 1.2.002 Study.
Clin Colorectal Cancer
; 14(2): 91-8, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25666295
13.
Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer.
Clin Cancer Res
; 21(24): 5469-79, 2015 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26341920
14.
Research and standard of care: lung cancer in romania.
Am Soc Clin Oncol Educ Book
; : 437-41, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-24451777
15.
A phase II, open-label, randomized study to assess the efficacy and safety of AZD6244 (ARRY-142886) versus pemetrexed in patients with non-small cell lung cancer who have failed one or two prior chemotherapeutic regimens.
J Thorac Oncol
; 5(10): 1630-6, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20802351
16.
Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial.
World J Gastroenterol
; 16(25): 3133-43, 2010 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-20593498
17.
A randomised Phase III trial of glufosfamide compared with best supportive care in metastatic pancreatic adenocarcinoma previously treated with gemcitabine.
Eur J Cancer
; 45(9): 1589-96, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19188061
18.
Darbepoetin alpha for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
J Clin Oncol
; 26(7): 1040-50, 2008 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18227526
19.
Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancer.
J Thorac Oncol
; 3(6): 623-30, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18520802